Publication:
Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer

Simple item page
dc.contributor.coauthorN/A
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorSezer, Havva
dc.contributor.kuauthorDereli, Dilek Yazıcı
dc.contributor.kuauthorDeyneli, Oğuzhan
dc.contributor.kuauthorMeriçöz, Çisel Aydın
dc.contributor.kuauthorEsin, Ayla
dc.contributor.kuauthorAlper, Emrah
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:05:41Z
dc.date.issued2020
dc.description.abstractNot required for Clinical Vignette.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.WoSQuartileQ4
dc.identifier.doi10.5603/EP.a2020.0012
dc.identifier.eissn2299-8306
dc.identifier.embargoN/A
dc.identifier.endpage284
dc.identifier.issn0423-104X
dc.identifier.issue3
dc.identifier.pubmed32154575
dc.identifier.scopus2-s2.0-85089611197
dc.identifier.startpage283
dc.identifier.urihttps://doi.org/10.5603/EP.a2020.0012
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8852
dc.identifier.volume71
dc.identifier.wos000562953800015
dc.keywordsEmpagliflozin
dc.keywordsEuglycaemic diabetic ketoacidosis
dc.keywordsPancreas cancer
dc.language.isoeng
dc.publisherVia Medica
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofEndokrynologia Polska
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectEndocrinology
dc.subjectMedicine
dc.subjectOncology
dc.titleEmpagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer
dc.typeOther
dspace.entity.typePublication
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Collections

Publications without Fulltext